BioNTech Reaches $1.26 Billion Settlement Over COVID-19 Vaccine Royalties

Washington, U.S. – BioNTech (22UAy.DE), the German biotech firm that developed a COVID-19 vaccine in partnership with Pfizer (PFE.N), has resolved royalty disputes with the U.S. National Institutes of Health (NIH) and the University of Pennsylvania (Penn). The company announced two separate settlement agreements totalling $1.26 billion to address allegations of underpaid royalties related to…

Read More

US DOD admits to Chinese COVID jab smear campaign in Philippines

The US Department of Defense admitted to intentionally spreading discrediting information about the Chinese Sinovac vaccine’s effectiveness in the Philippines during the COVID-19 pandemic, according to a Reuters report citing a classified government document. The disclosure first came to light when Harry Roque, the spokesperson for former Philippine President Rodrigo Duterte, mentioned it in his…

Read More

Safety concerns: AstraZeneca withdraws COVID-19 vaccine from circulation

Pharmaceutical giant, AstraZeneca has formally asked the European Medicines Agency to withdraw its COVID-19 vaccine authorisation. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorisation holder.” According to Africanews, the vaccine, initially approved in January…

Read More